Induction of hypoxia by vascular disrupting agents and the significance for their combination with radiation therapy

Author： Iversen Ane B.   Busk Morten   Horsman Michael R.  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.52, Iss.7, 2013-10, pp. : 1320-1326

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of cell cycle perturbations in the combination therapy of chemotherapeutic agents and radiation

By Pauwels Bea   Wouters An   Peeters Marc   Vermorken Jan B   Lardon Filip  

Future Oncology, Vol. 6, Iss. 9, 2010-09 ,pp. : 1485-1496

Future Medicine

Access to resources Recommend Favorite

Small Molecule Vascular Disrupting Agents: Potential New Drugs for Cancer Treatment

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 1, 2007-01 ,pp. : 79-101

Bentham Science Publishers

Access to resources Recommend Favorite

ASA404: a tumor vascular-disrupting agent with broad potential for cancer therapy

By Baguley Bruce C   McKeage Mark J  

Future Oncology, Vol. 6, Iss. 10, 2010-10 ,pp. : 1537-1543

Future Medicine

Access to resources Recommend Favorite

Vascular Density in Relation to the Outcome of Radiation Therapy: A Review

By Révész L.  

International Journal of Radiation Biology, Vol. 60, Iss. 1-2, 1991-07 ,pp. : 179-182

Informa Healthcare

Access to resources Recommend Favorite

Radiation and hypoxia inducible gene therapy systems: Basic radiation research into the new millennium (Guest Editor: Michael C. Joiner)

By Scott Simon D.  

Cancer and Metastasis Reviews, Vol. 23, Iss. 3-4, 2004-08 ,pp. : 269-276

Springer Publishing Company

Access to resources Recommend Favorite